Charles Sternberg, Associate Editor05.19.22
Cionic, a company committed to helping people with mobility differences move more independently through bionic clothing, has named the following experts to its Scientific Advisory Board:
These newly appointed physicians, scientists, and members of academia will provide essential feedback and identify additional opportunities for Cionic’s programs and technology. Through their vast experience and depth and breadth of practical knowledge, the Board will provide valuable insights into the needs and wants of the Cionic customer population. The Board will also guide Cionic’s research efforts with regard to clinicians, both in terms of metrics as well as desired patient outcomes.
“We’re thrilled to have a highly recognized and experienced group comprise Cionic’s Scientific Advisory Board,” said Jeremiah Robison, founder and CEO of Cionic. “Cionic is addressing a multitude of conditions with our breakthrough technology, and it was important for us to form a diverse panel to best address the varied needs of the millions of people who live with mobility challenges. Our Board will continue to help move Cionic’s vision forward, not only as a provider of effective bionic clothing for people with mobility challenges, but as a trailblazing medical company at the forefront of how technology and data can be used to help people live more freely and independently.”
The Cionic Scientific Advisory Board will play a critical role in delivering effective new therapies to market. They bring deep expertise in clinical pathologies and patient care that will serve to guide the company's product and research roadmap and help ensure that Cionic’s products are as impactful as possible.
Each member of the Cionic Scientific Advisory Board is an expert in their field and brings unique disciplines that will help Cionic adapt its technology to ensure the Neural Sleeve is as beneficial and effective as possible.
“I’m honored to join Cionic’s Scientific Advisory Board. Jeremiah and his team have created something exciting and possibly revolutionary,” said Dr. Charles Adler of the Mayo Clinic. “I’m looking forward to lending my expertise to help Cionic further develop and refine their technology and product offerings to benefit as many people as possible.”
“My experience at Stanford with technology development to assist patients recovering from stroke has taught me that innovative, next-generation technologies have a lot to offer to patients eager to recover function after a debilitating diagnosis or accident,” according to Dr. Kara Flavin. “I find the Cionic vision very compelling, and am eager to help the company offer the most effective solution.”
- Charles H. Adler, M.D., Ph.D., Professor of Neurology, Mayo Clinic College of Medicine
- Carrolee Barlow, M.D., Ph.D., Chief Medical Officer of ESCAPE Bio
- Alberto Botter, Ph.D., Professor of Biomedical Engineering, Polytechnic University of Turin
- Kara Flavin, M.D., Clinical Assistant Professor, Orthopaedic Surgery Clinical Assistant Professor, Neurology & Neurological Sciences, Stanford University
- Richard D. Zorowitz, M.D., Professor of Rehabilitation Medicine, Georgetown University Medical Center
Delivering New Therapies to Market
Cionic recently announced the Cionic Neural Sleeve, the first bionic clothing for mobility impairment. The Cionic Neural Sleeve helps to improve walking, increase strength and range of motion, facilitate muscle re-education, and has already been cleared and validated by the FDA.These newly appointed physicians, scientists, and members of academia will provide essential feedback and identify additional opportunities for Cionic’s programs and technology. Through their vast experience and depth and breadth of practical knowledge, the Board will provide valuable insights into the needs and wants of the Cionic customer population. The Board will also guide Cionic’s research efforts with regard to clinicians, both in terms of metrics as well as desired patient outcomes.
“We’re thrilled to have a highly recognized and experienced group comprise Cionic’s Scientific Advisory Board,” said Jeremiah Robison, founder and CEO of Cionic. “Cionic is addressing a multitude of conditions with our breakthrough technology, and it was important for us to form a diverse panel to best address the varied needs of the millions of people who live with mobility challenges. Our Board will continue to help move Cionic’s vision forward, not only as a provider of effective bionic clothing for people with mobility challenges, but as a trailblazing medical company at the forefront of how technology and data can be used to help people live more freely and independently.”
The Cionic Scientific Advisory Board will play a critical role in delivering effective new therapies to market. They bring deep expertise in clinical pathologies and patient care that will serve to guide the company's product and research roadmap and help ensure that Cionic’s products are as impactful as possible.
Each member of the Cionic Scientific Advisory Board is an expert in their field and brings unique disciplines that will help Cionic adapt its technology to ensure the Neural Sleeve is as beneficial and effective as possible.
“I’m honored to join Cionic’s Scientific Advisory Board. Jeremiah and his team have created something exciting and possibly revolutionary,” said Dr. Charles Adler of the Mayo Clinic. “I’m looking forward to lending my expertise to help Cionic further develop and refine their technology and product offerings to benefit as many people as possible.”
“My experience at Stanford with technology development to assist patients recovering from stroke has taught me that innovative, next-generation technologies have a lot to offer to patients eager to recover function after a debilitating diagnosis or accident,” according to Dr. Kara Flavin. “I find the Cionic vision very compelling, and am eager to help the company offer the most effective solution.”